Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    October 2017
  1. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
    Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
    Oncogene. 2017;36:6020-6029.
    PubMed     Text format     Abstract available


  2. REN T, Zhang H, Wang J, Zhu J, et al
    MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells.
    Oncogene. 2017;36:5897-5909.
    PubMed     Text format     Abstract available


  3. NAKAYAMA M, Sakai E, Echizen K, Yamada Y, et al
    Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Oncogene. 2017;36:5885-5896.
    PubMed     Text format     Abstract available


  4. GUO P, Ma X, Zhao W, Huai W, et al
    TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Oncogene. 2017 Oct 2. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    September 2017
  5. XIE X, Guo P, Yu H, Wang Y, et al
    Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  6. TRAN DDH, Kessler C, Niehus SE, Mahnkopf M, et al
    Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.
    Oncogene. 2017 Sep 4. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  7. FENG GX, Li J, Yang Z, Zhang SQ, et al
    Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.
    Oncogene. 2017 Aug 28. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  8. LI J, Huang Q, Long X, Guo X, et al
    Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.
    Oncogene. 2017;36:4901-4912.
    PubMed     Text format     Abstract available


  9. HAN H, Yang B, Wang W
    Angiomotin-like 2 interacts with and negatively regulates AKT.
    Oncogene. 2017;36:4662-4669.
    PubMed     Text format     Abstract available


  10. LI J, Hu SB, Wang LY, Zhang X, et al
    Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  11. GOVAERE O, Petz M, Wouters J, Vandewynckel YP, et al
    The PDGFRalpha-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  12. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer.
    Oncogene. 2017;36:4405-4414.
    PubMed     Text format     Abstract available


    July 2017
  13. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  14. FAN LC, Shiau CW, Tai WT, Hung MH, et al
    SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  15. XIONG H, Ni Z, He J, Jiang S, et al
    LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Oncogene. 2017;36:3528-3540.
    PubMed     Text format     Abstract available


    May 2017
  16. CROSAS-MOLIST E, Bertran E, Rodriguez-Hernandez I, Herraiz C, et al
    The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination.
    Oncogene. 2017;36:3002-3014.
    PubMed     Text format     Abstract available


  17. CHI HC, Chen SL, Lin SL, Tsai CY, et al
    Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  18. XIN B, Yamamoto M, Fujii K, Ooshio T, et al
    Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    March 2017
  19. CHEN H, Cai W, Chu ES, Tang J, et al
    Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  20. HU X, Zhao Y, Wei L, Zhu B, et al
    CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  21. ZHOU M, Mok MT, Sun H, Chan AW, et al
    The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  22. DENG L, Tang J, Yang H, Cheng C, et al
    MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  23. ZHANG HR, Wang XD, Yang X, Chen D, et al
    An FGFR inhibitor converts the tumor promoting effect of TGF-beta by the induction of fibroblast-associated genes of hepatoma cells.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2017
  24. BATTISTELLI C, Cicchini C, Santangelo L, Tramontano A, et al
    The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition.
    Oncogene. 2017;36:942-955.
    PubMed     Text format     Abstract available


  25. SUN H, Peng Z, Tang H, Xie D, et al
    Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-beta signaling in and promote progression of hepatocellular carcinoma.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  26. LIN Y, Yang X, Liu W, Li B, et al
    Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  27. HERMANNS C, Hampl V, Holzer K, Aigner A, et al
    The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  28. MENG Z, Ma X, Du J, Wang X, et al
    CAMK2gamma antagonizes mTORC1 activation during hepatocarcinogenesis.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  29. FAN H, Cui Z, Zhang H, Mani SK, et al
    DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
    Oncogene. 2016 Oct 31. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  30. LIAO PH, Hsu HH, Chen TS, Chen MC, et al
    Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  31. HAASE G, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  32. DENG Y, Cheng J, Fu B, Liu W, et al
    Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    August 2016
  33. CAO C, Zhang T, Zhang D, Xie L, et al
    The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.
    Oncogene. 2016 Aug 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  34. ZHOU X, Zhang CZ, Lu SX, Chen GG, et al
    miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
    Oncogene. 2016 Aug 8. doi: 10.1038/onc.2016.
    PubMed     Text format    


  35. LIN KT, Shann YJ, Chau GY, Hsu CN, et al
    Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.
    Oncogene. 2016 Aug 1. doi: 10.1038/onc.2016.
    PubMed     Text format    


    May 2016
  36. SHEN J, Tsoi H, Liang Q, Chu ES, et al
    Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
    Oncogene. 2016 May 2. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  37. LIU F, Yuan JH, Huang JF, Yang F, et al
    Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  38. WU J, Lu M, Li Y, Shang YK, et al
    Regulation of a TGF-beta1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  39. NA TY, Ka NL, Rhee H, Kyeong D, et al
    Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    March 2016
  40. MORIOKA S, Sai K, Omori E, Ikeda Y, et al
    TAK1 regulates hepatic lipid homeostasis through SREBP.
    Oncogene. 2016 Mar 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    February 2016
  41. HUNG MH, Chen YL, Chu PY, Shih CT, et al
    Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  42. AHRONIAN LG, Zhu LJ, Chen YW, Chu HC, et al
    A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2016
  43. WANG W, Liao P, Shen M, Chen T, et al
    SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62.
    Oncogene. 2016;35:491-500.
    PubMed     Text format     Abstract available


  44. URTASUN R, Elizalde M, Azkona M, Latasa MU, et al
    Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression.
    Oncogene. 2016 Jan 25. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    July 2015
  45. ZHU G, Li X, Guo B, Ke Q, et al
    PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
    Oncogene. 2015 Jul 27. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    March 2015
  46. PARISI T, Bronson RT, Lees JA
    Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer.
    Oncogene. 2015 Mar 9. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: